Weekly News Round-up – 5/3/21

In the news this week, Merck & J&J team up to boost COVID vaccine supply, while Novavax hopes to have its vaccine approved in May. In other news, Pfizer’s COVID vaccine may less effective in obese individuals, and Merck buys...

11 hours ago
R&D,Bioprocess,Clinical Development,Weekly Roundups,Biology

Weekly News Round-up – 5/3/21

In the news this week, Merck & J&J team up to boost COVID vaccine supply, while Novavax hopes to have its vaccine approved in May. In other news, Pfizer’s COVID vaccine may less effective in obese individuals, and Merck buys...

11 hours ago

Data Capture, Integration and Storage in Decentralised Trials

Decentralisation of virtual trials has grown rapidly during the COVID-19 pandemic, changing the nature of clinical trials for a number of large and small pharma companies. While this new way of conducting clinical operations promises to reduce costs and increase...

5 days ago
R&D,Clinical Development,Clinical Operations,Precision and Personalised Medicine,News

Data Capture, Integration and Storage in Decentralised Trials

Decentralisation of virtual trials has grown rapidly during the COVID-19 pandemic, changing the nature of clinical trials for a number of large and small pharma companies. While this new way of conducting clinical operations promises to reduce costs and increase...

5 days ago

Weekly News Round-up – 26/2/21

In the news this week, Moderna is set to make a profit for the first time with huge profit expectations for 2021. In other news, Icon acquires PRA for $12 billion to create a ‘mega-CRO’, and the first variant of...

1 week ago
R&D,Clinical Development,Weekly Roundups,Biology

Weekly News Round-up – 26/2/21

In the news this week, Moderna is set to make a profit for the first time with huge profit expectations for 2021. In other news, Icon acquires PRA for $12 billion to create a ‘mega-CRO’, and the first variant of...

1 week ago

A Look Ahead: Clinical Trials and PV Over the Next 5 Years

Given the severity of industry disruptions in 2020, and the surge in innovation and development that followed, the future of clinical operations seems more clouded than ever. Proventa set out to find out more about the future of Clinical Trials...

4 weeks ago
Pharmacovigilance,Clinical Development,Clinical Operations,News

A Look Ahead: Clinical Trials and PV Over the Next 5 Years

Given the severity of industry disruptions in 2020, and the surge in innovation and development that followed, the future of clinical operations seems more clouded than ever. Proventa set out to find out more about the future of Clinical Trials...

4 weeks ago

Weekly News Round-up – 22/1/21

In the news this week, collaboration within the pharma industry continues to struggle as it is revealed that the WHO’s platform for industry collaboration over COVID-19 goes entirely unused. In other news, Merck finally loses its hepatitis C patent infringement...

1 month ago
R&D,Bioprocess,Clinical Development,Weekly Roundups,News

Weekly News Round-up – 22/1/21

In the news this week, collaboration within the pharma industry continues to struggle as it is revealed that the WHO’s platform for industry collaboration over COVID-19 goes entirely unused. In other news, Merck finally loses its hepatitis C patent infringement...

1 month ago

The Importance of Efficacy in COVID-19 Vaccines

With a number of competing vaccines rapidly rolling out around the world, for many COVID-19 seems an already receding issue. The leading vaccines - from AstraZeneca/University of Oxford, from Pfizer and from Moderna - are in the process of manufacturing...

2 months ago
R&D,Clinical Development,Clinical Operations,Biology,News

The Importance of Efficacy in COVID-19 Vaccines

With a number of competing vaccines rapidly rolling out around the world, for many COVID-19 seems an already receding issue. The leading vaccines - from AstraZeneca/University of Oxford, from Pfizer and from Moderna - are in the process of manufacturing...

2 months ago

Weekly News Round-up – 15/1/21

In the news this week, COVID vaccine production continues to advance, with Regeneron signing a new $2.6 billion deal in the US, the J&J one-shot looks set to distribute in March 2021, and two inhaler treatments advance in trials. In...

2 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups,News

Weekly News Round-up – 15/1/21

In the news this week, COVID vaccine production continues to advance, with Regeneron signing a new $2.6 billion deal in the US, the J&J one-shot looks set to distribute in March 2021, and two inhaler treatments advance in trials. In...

2 months ago

Weekly News Round-up – 8/1/21

Vaccines dominate the news this week, as multiple companies come ever closer to having their products greenlit for market. Janssen’s single-shot vaccine could be approved within weeks, while Moderna’s vaccine sees EU take-up and AZ/Oxford University’s product seems set for...

2 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups,News

Weekly News Round-up – 8/1/21

Vaccines dominate the news this week, as multiple companies come ever closer to having their products greenlit for market. Janssen’s single-shot vaccine could be approved within weeks, while Moderna’s vaccine sees EU take-up and AZ/Oxford University’s product seems set for...

2 months ago

How COVID-19 has Affected Clinical Operations

The COVID-19 pandemic has disrupted sectors and organisations around the world. But one of the most vital fields that has seen significant impact is in clinical operations. Trials and supply chains have had to be rapidly changed to accommodate the...

5 months ago
Clinical Development,Clinical Operations,News

How COVID-19 has Affected Clinical Operations

The COVID-19 pandemic has disrupted sectors and organisations around the world. But one of the most vital fields that has seen significant impact is in clinical operations. Trials and supply chains have had to be rapidly changed to accommodate the...

5 months ago

Weekly News Round-up – 11/9/20

In the news this week, Oxford University and AstraZeneca have temporarily suspended their joint COVID-19 vaccine trials over safety fears as a subject falls ill. In other news, GSK and Sanofi begin their own COVID trials, and a group of...

6 months ago
Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 11/9/20

In the news this week, Oxford University and AstraZeneca have temporarily suspended their joint COVID-19 vaccine trials over safety fears as a subject falls ill. In other news, GSK and Sanofi begin their own COVID trials, and a group of...

6 months ago